Buy Lysergic acid ethylamide (LAE-32 or LAE) Cas 478-99-9
Buy Lysergic acid ethylamide (LAE-32 or LAE) Cas 478-99-9
Lysergic acid ethylamide (LAE-32 or LAE), also known as N-ethyllysergamide, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD).[1][2][3] It is the analogue of LSD in which one of the ethyl groups on the amide moiety has been removed.[1][2]
The drug is reported to have some LSD-like effects but is weaker and shorter-lasting, with an active dose reported to be between 0.5 and 1.6 mg by different routes of administration including subcutaneous or intramuscular injection and oral administration.[1][2][4] Side effects like apathy and sedation have been reported.[1]
Analogues of LAE-32 include LSD, MLA-74 (1-methyl-LAE), ALA-10 (1-acetyl-LAE; 1A-LAE), lysergic acid methylamide (LAM), lysergic acid propylamide (LAP), LME-54 (lysergic acid methylethylamide), and LEP-57 (lysergic acid ethylpropylamide; EPLA), among others.[1][2]
LAE-32 was first described in the scientific literature by Albert Hofmann and colleagues by 1955.[5] It was studied by the CIA as part of Project MKULTRA. Documents published by the CIA under the Freedom of Information Act suggest it causes “a schizophrenia-like condition” but it allows people with schizophrenia to remain indifferent to their disorder.[citation needed] The drug has also been studied in psychedelic-assisted psychotherapy.[4] It is not a controlled substance in Canada as of 2025.[6]
Reviews
There are no reviews yet.